Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$45,943,997
+$5,676,281 QoQ
Shares Held
4,924,330
+22.4% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,278 | $130,014,715 | |
| 2 | HLN |
Haleon plc
This page
|
4,924,330 | $45,943,997 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
253,026 | $42,644,999 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
74,303 | $40,259,592 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
976,361 | $24,028,242 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
559,389 | $19,394,014 | |
| 7 | VTRS |
Viatris Inc
|
1,175,495 | $18,666,859 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,150,820 | $18,447,643 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,943,997 | 4,924,330 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $40,267,716 | 4,022,749 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $37,678,472 | 3,726,852 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $32,758,034 | 3,651,955 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $33,548,608 | 3,235,160 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $33,224,227 | 3,228,788 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $31,069,612 | 3,256,773 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $34,930,577 | 3,301,567 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $30,719,615 | 3,719,082 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $28,546,214 | 3,362,334 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $15,928,925 | 1,935,471 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $16,091,842 | 1,931,794 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,259,605 | 2,059,619 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $19,497,325 | 2,395,249 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $25,514,640 | 3,189,330 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $20,599,406 | 3,382,497 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||